Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies
Time: 4:30 pm
day: Conference Day One
Details:
- Streamlining therapeutic index-focused discovery and drug development for TRTs with clinical pharmacology considerations and model-informed drug development (MIDD) concepts
- Understanding dose optimization requirements for TRT in the clinical pharmacology regulatory landscape while complying with the FDA’s Project Optimus initiative to optimize oncology drug dosage
- Discover how MIDD, including quantitative systems pharmacology (QSP) and pharmacometrics, help drive rational drug design, patient selection, and inform dosage optimization
